SCHEDULE: State Street Discloses 5.9% Stake in Novavax

State Street Corporation has reported a 5.9% beneficial ownership stake in Novavax Inc., holding over 9.5 million shares as of December 31, 2025.

Summary

• State Street Corporation, a parent holding company, has filed a Schedule 13G indicating beneficial ownership of 9,523,646 shares of Novavax Inc. common stock.
• This ownership represents 5.9% of Novavax's outstanding common stock.
• State Street Corporation holds shared voting power over 9,020,626 shares and shared dispositive power over all 9,523,646 shares.
• The filing was made pursuant to Rule 13d-1(b), signifying that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Novavax.
• The beneficial ownership is held through various investment adviser subsidiaries, including SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, State Street Global Advisors Trust Company, and State Street Global Advisors, Ltd.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive disclosure. It's a routine filing for a large institutional investor, confirming a significant but passive stake, which can be seen as a vote of confidence in the company's long-term prospects by a major asset manager.

Positives

• The disclosure of a significant institutional holding by State Street Corporation, a major financial institution, may signal continued institutional interest in Novavax Inc.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G are routine disclosures for large asset managers such as State Street Corporation. While it confirms a significant stake, it does not necessarily indicate a new strategic move, but rather reflects the ongoing management of various investment portfolios that include Novavax shares.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder may provide a degree of confidence, indicating that a major financial institution sees value in Novavax's stock.

Key Dates

Keywords

Novavax, State Street Corporation, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Schedule 13G, NVAX